RapidAI
Menlo Park
About RapidAI
RapidAI empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $100.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jul 2023)
- Website: rapidai.com
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/rapidai-119112 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.